関連する実験動画
Updated: Jan 7, 2026

08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
13.8K
甲状腺機能亢進症が造血器系に及ぼす影響
Wen Yang1, Yanting Li1, Li Ma1
1Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Yunnan, China.
Clinical and experimental medicine
|December 20, 2025
まとめ
甲状腺機能亢進症は、骨髄の造血幹/前駆細胞(HSPC)を損なうことにより血液学的異常を引き起こす。これは、アポトーシス増加ではなく、細胞周期停止による血球数減少につながる。
科学分野:
- 内分泌学;血液学;細胞生物学
背景:
- 甲状腺機能亢進症は血液学的異常と関連しているが、そのメカニズムは不明である。;これらのメカニズムを理解することは、患者管理にとって重要である。
研究 の 目的:
- 甲状腺機能亢進症における血液学的異常の細胞メカニズムを調査すること。;甲状腺機能亢進症患者と対照群の血球数を比較すること。;マウスモデルにおける造血幹/前駆細胞(HSPC)を調べること。
主な方法:
- 166人の甲状腺機能亢進症患者と56人の対照群の全血球計算を比較した。;甲状腺機能亢進症のマウスモデルを利用した。;骨髄HSPC(量、細胞周期、アポトーシス)を分析するためにフローサイトメトリーを使用した。
主要な成果:
- 甲状腺機能亢進症患者では、白血球(好中球、好酸球、好塩基球)および赤血球パラメータ(HGB、HCT、MCV、MCH、MCHC)の減少が認められた。;女性患者では変化がより顕著であった。;甲状腺機能亢進症マウスでは、細胞周期停止による骨髄HSPCの減少を伴う白血球減少症および好中球減少症が認められた。
結論:
- 甲状腺ホルモンの上昇は、骨髄HSPCの細胞周期停止を誘導し、その増殖と分化を妨げる。;この細胞メカニズムは、末梢血球数変化を甲状腺機能亢進症で説明する。;本研究結果は、甲状腺機能亢進症関連の血液学的問題と潜在的な介入に関する洞察を提供する。
関連する概念動画
Functions of Thyroid Hormones
4.9K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.9K
Synthesis and Regulation of Thyroid Hormones
7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Disorders of Leukocytes
1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K

